New Cationic Carbohydrate-Modified Amphiphiles and Liposomes for Effective Delivery of Short Nucleic Acids into Eukaryotic Cells DOI
Elena V. Shmendel,

A. O. Buyanova,

Oleg V. Markov

et al.

Russian Journal of Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 50(6), P. 2379 - 2396

Published: Dec. 1, 2024

Language: Английский

Understanding the theranostic potential of quantum dots in cancer management DOI
Mohammad Sameer Khan,

Afsana Sheikh,

Mohammed A. S. Abourehab

et al.

Materials Today Communications, Journal Year: 2023, Volume and Issue: 36, P. 106424 - 106424

Published: June 12, 2023

Language: Английский

Citations

26
Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy DOI

Afsana Sheikh,

Mohammed A. S. Abourehab, Alaa S. Tulbah

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2023, Volume and Issue: 86, P. 104745 - 104745

Published: July 7, 2023

Language: Английский

Citations

24
Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics DOI Creative Commons
Chiara Battisegola, Chiara Billi, Maria Cristina Molaro

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(3), P. 308 - 308

Published: Feb. 27, 2024

D-galactose, a simple natural compound, has been investigated as powerful scaffold for drug delivery, diagnostics, and theranostics due to its distinctive properties interactions with specific cell receptors. In the field of galactose functions ligand selectively target cells expressing receptors, such hepatocytes, macrophages, cancer cells. The direct attachment main or drug-loaded nanoparticles liposomes enhances cellular uptake, thereby improving delivery intended Galactose also found be useful in diagnostics. Specifically, diagnostic tests based on galactose, elimination capacity test, are utilized evaluate liver function assess disease well hepatic functional reserve. Additionally, galactose-based theranostic agents can designed by combining capabilities. This review is an update our previous concerning broad spectrum possibilities exploiting D-galactose vector prodrug design synthetic strategies that allow realization, jointly diagnostics theranostics, highlight versatility this interesting vector.

Language: Английский

Citations

10
Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy DOI
M H Miran Beygi, Fatemeh Oroojalian, Seyed Samad Hosseini

et al.

Progress in Materials Science, Journal Year: 2023, Volume and Issue: 140, P. 101209 - 101209

Published: Nov. 3, 2023

Language: Английский

Citations

20
Drug loaded bioglass nanoparticles and their coating for efficient tissue and bone regeneration DOI Open Access

Sukhmeet Tangri,

Nazeer Hasan, Jasmeet Kaur

et al.

Journal of Non-Crystalline Solids, Journal Year: 2023, Volume and Issue: 616, P. 122469 - 122469

Published: July 3, 2023

Language: Английский

Citations

15
Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat DOI Creative Commons
Mehdi Sanati, Amir R. Afshari,

Seyed Sajad Ahmadi

et al.

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2023, Volume and Issue: 1869(6), P. 166720 - 166720

Published: April 14, 2023

Language: Английский

Citations

12
Unlocking the Power of Sugar: Carbohydrate Ligands as Key Players in Nanotherapeutic-Assisted Targeted Cancer Therapy DOI
Rajan Swami,

Sahil Vij,

Shubham Sharma

et al.

Nanomedicine, Journal Year: 2024, Volume and Issue: 19(5), P. 431 - 453

Published: Jan. 30, 2024

Cancer cells need as much 40-times more sugar than their normal cell counterparts. This demand is attained by the excessive expression of inimitable transporters on surface cancer cells, driven voracious appetite for carbohydrates. Nanotechnological advances drive research utilizing ligand-directed therapeutics and diverse carbohydrate analogs. The precise delivery these therapeutic cargos not only mitigates toxicity associated with chemotherapy but also reduces grim toll mortality morbidity among patients. in-depth review explores potential ligands in advanced treatment using nanoparticles. It offers a broader perspective beyond usual ways we deliver drugs, potentially changing way fight cancer.

Language: Английский

Citations

4
Scouting the efficacy of targeted gold nanoparticles in the landscape of cancer therapy DOI
Mahak Fatima, Garima Gupta,

Swaranjeet Arora

et al.

European Polymer Journal, Journal Year: 2024, Volume and Issue: 209, P. 112924 - 112924

Published: March 11, 2024

Language: Английский

Citations

4
αvβ3 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment DOI
Prashant Kesharwani,

Jyoti Chandra,

Shahid Karim

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 96, P. 105663 - 105663

Published: April 16, 2024

Language: Английский

Citations

4
Harnessing the potential of de-sulfated heparin for targeted drug delivery: A three-component approach exemplified by conjugation with galactose and paclitaxel DOI
Jing Yang,

Xiongyan Meng,

Yong Rao

et al.

Carbohydrate Polymers, Journal Year: 2024, Volume and Issue: 333, P. 121986 - 121986

Published: Feb. 25, 2024

Language: Английский

Citations

3